✨ Medicines Act Notices




24 FEBRUARY NEW ZEALAND GAZETTE 909

Area: 6.0829 hectares, more or less.
Also Section 6, Block IX, Oroua Survey District.

Area: 1017 square metres, more or less.

As witness the hand of Her Excellency the Governor-General, signed this 25th day of February 1994.

B. ENGLISH, Parliamentary Under Secretary.

gol1295


Medicines Act 1981

Consent to the Distribution of Changed Medicines

Pursuant to section 24(5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Cyclosporin A 100 mg/ml in 50 ml Oral solution Sandoz Pharma Limited, Basle, Switzerland Sandimmun
Cyclosporin A 25 mg, 100 mg Capsules Sandoz Pharma Limited, Basle, Switzerland Sandimmun
Enoxaparin 20 mg/0.2 ml, 40 mg/0.4 ml, Injection Rhone-Poulenc Sante Propharm, Maisons-Alfort, France Clexane
60 mg/0.6 ml, 80 mg/0.8 ml, 100 mg/1 ml
Alprostadil 20 mcg/ml Powder for reconstitution for injection Upjohn SA, Puurs, Belgium Caverject
Ciclopirox 8% Nail lacquer Hoechst AG, Frankfurt (Main), Germany Batrafen
Budesonide 0.025% w/v Lotion Royal Gist-Brocades Pharma BV, Meppel, The Netherlands Preferid
Somatropin (human growth hormone rDNA origin) 4IU/ml, 16IU/ml Lyophilized powder for reconstitution for injection Eli Lilly International Corporation, Indianapolis, Indiana, United States of America and Lilly France SA, Fegersheim, France Humatrope for injection
Diclofenac 46.5 mg (equivalent to 50 mg diclofenac sodium) Tablet Ciba-Geigy Limited, Stein, Switzerland and Ciba-Geigy Pharmaceuticals Division, Horsham, West Sussex, England Voltarol D
Olsalazine sodium 500 mg Tablet Kabi Pharmacia AB, Uppsala, Sweden Dipentum
Hydrocortisone acetate 1% w/w Topical cream The Boots Company PLC., Nottingham, England Hc45 Hydrocortisone Cream
Inactivated hepatitis A virus 1440 ELISA units/1 ml Solution for injection SmithKline Beecham Biologicals, Rixensart, Belgium Havrix 1440 Vaccine
Atenolol 50 mg/12.5 mg chlorthalidone, atenolol 100 mg/25 mg chlorthalidone Tablets Gerard Laboratories, Dublin, Ireland Lo-Ten C
  • This replaces the entry in the notice published in the New Zealand Gazette, 13 August 1992, 127, notice number 7425, page 2768

Dated this 17th day of February 1994.

C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.

gol1433


Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Mesalazine 400 mg Tablet SmithKline Beecham Pharma GmbH, Gronau/Leine, Germany Asacol
Famotidine 20 mg, 40 mg Wafer R P Scherer, Blagrove, Swindon, Wiltshire, England Pepcidine RPD
Cilazapril 5 mg, hydrochlorothiazide 12.5 mg Tablet F Hoffmann-La Roche & Co, Aktiengesellschaft, Basle, Switzerland Inhibace Plus


Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1994, No 16


NZLII PDF NZ Gazette 1994, No 16





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
17 February 1994
Medicines, Distribution, Consent, Schedule, Medicines Act 1981
  • C. Lovelace, Director-General of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
Medicines, Distribution, Consent, Schedule, Medicines Act 1981